Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate
Acer Therapeutics Announces Initiation of Two Investigator-Sponsored Trials of ACER-801 (Osanetant) in Men with Adenocarcinoma of the Prostate - read this article along with other careers information, tips and advice on BioSpace
Czech Republic Elizabeth Wulff Burchfield William Parker Jim Denike Nick Colangelo Division Of Urologic Oncology
Source: biospace.com